180 Life Sciences Valor da empresa
Qual é o Valor da empresa de 180 Life Sciences?
O Valor da empresa de 180 Life Sciences Corp. é $8.60M
Qual é a definição de Valor da empresa?
O valor da empresa é uma medida do valor total de mercado de uma empresa. É calculado como capitalização de mercado com dívida, participação minoritária e ações preferenciais menos o total de caixa e equivalentes de caixa.
It is a sum of claims by all claimants including creditors (secured and unsecured) and shareholders (preferred and common). Enterprise value is one of the fundamental metrics used in business valuation, financial modeling, accounting, portfolio analysis, and risk analysis. Enterprise value is more comprehensive than market capitalization, which only reflects common equity and is considered more representative of a company’s value. Enterprise value reflects the opportunistic nature of business and may change substantially over time because of both external and internal conditions.
Enterprise value can be negative if the company holds abnormally high amounts of cash that is not reflected in the market value of the stock and total capitalization. Cash is subtracted in the calculation because it reduces the net cost to a potential purchaser. The effect applies whether the cash is used to issue dividends or to pay down debt. Value of minority interest is added because it reflects the claim on assets consolidated into the firm in question. Value of associate companies is subtracted because it reflects the claim on assets consolidated into other firms. EV should also include such special components as unfunded pension liabilities, employee stock options, environmental provisions, abandonment provisions, and so on, since they also reflect claims on the company.
Valor da empresa de empresas na Setor Health Care em NASDAQ em comparação com 180 Life Sciences
O que 180 Life Sciences faz?
180 Life Sciences Corp., a clinical-stage biotechnology company, engages in the development of novel drugs for unmet medical needs in chronic pain, inflammation, inflammatory diseases, and fibrosis. Its product development platforms in Phase IIb/III clinical trials include Fibrosis and anti-tumour necrosis factor (Anti-TNF) platform, which focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which are man-made derivatives of CBD; and a7nAChR platform, which focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, California.
Empresas com valor da empresa semelhantes a 180 Life Sciences
- Lamtex tem Valor da empresa de $8.57M
- Enertime SA tem Valor da empresa de $8.58M
- Invex Therapeutics Ltd tem Valor da empresa de $8.58M
- Invex Therapeutics Ltd tem Valor da empresa de $8.58M
- KalNorth Gold Mines tem Valor da empresa de $8.59M
- SportsHero tem Valor da empresa de $8.59M
- 180 Life Sciences tem Valor da empresa de $8.60M
- IDT Australia tem Valor da empresa de $8.60M
- InsuraGuest Technologies tem Valor da empresa de $8.60M
- Inventus Mining tem Valor da empresa de $8.60M
- Virat Crane Industries tem Valor da empresa de $8.60M
- Black Swan Graphene Inc tem Valor da empresa de $8.60M
- QMC Quantum Minerals Corp tem Valor da empresa de $8.61M